Chiara Maria Scandavini

Dr. Chiara Maria Scandavini


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2023 in International Journal of Surgery
Verified
Journal Article
Open access
RVRoberto Valente
Roberto Valente
Alessandro CoppolaAlessandro Coppola
Alessandro Coppola
CSChiara Maria Scandavini
Chiara Maria Scandavini
UAUrban Arnelo
Urban Arnelo
Pancreatic cancer is a highly lethal disease with a rising incidence. It is projected to become the second-leading cause of cancer-related mortality by 2030. The staging of pancreatic cancer can be broadly categorized into three groups: resectable cancers, locally advanced or borderline resectable cancers, and metastatic cancers. Endoscopy plays a crucial role in the management of pancreatic cancer for the establishment of the diagnosis, for the palliation of symptoms due to biliary and/or gastric outlet obstructions, and more recently, for the palliative ablation of cancer. The objective of this review is to provide an overview of the endoscopic evaluation and management of patients with pancreatic cancer. It will specifically cover the diagnostic approach utilizing endoscopic ultrasound, palliative interventions such as endoscopic retrograde cholangiopancreatography, and the emerging field of tumor debulking through radiofrequency ablation.

2 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SGSofia Svensson Di Giorgio
Sofia Svensson Di Giorgio
CSChiara Maria Scandavini
Chiara Maria Scandavini
Antonio MolinaroAntonio Molinaro
Antonio Molinaro
UAUrban Arnelo
Urban Arnelo
RVRoberto Valente
Roberto Valente
Primary sclerosing cholangitis is a rare, chronic, inflammatory disease of the biliary tree that leads to progressive ductal obliteration, hepatic dysfunction, and ultimately liver cirrhosis. Most patients eventually require liver transplantation or develop serious complications, the most severe being end-stage liver disease and cholangiocarcinoma. The global prevalence of PSC is rising and has been reported to reach up to 31.7 cases per 100,000 individuals, representing a significant challenge in both diagnosis and management. In this review, we aim to provide a clinically oriented overview of the diagnosis and management of PSC. Furthermore, we seek to highlight key challenges and areas of uncertainty that clinicians encounter in the diagnosis and treatment of patients with this complex disease.

18 December 2023 in International Journal of Surgery
Verified
Journal Article
Open access
RVRoberto Valente
Roberto Valente
CSChiara Maria Scandavini
Chiara Maria Scandavini
MCMarco Del Chiaro
Marco Del Chiaro
An abstract is unavailable. This article is available as a PDF only.

Verified
Journal Article
Open access
PDF file
CSChiara Maria Scandavini
Chiara Maria Scandavini
AWAlexander Waldthaler
Alexander Waldthaler
RVRoberto Valente
Roberto Valente
MHMari Helena Hult
Mari Helena Hult
FLFredrik Lindgren
Fredrik Lindgren
UAUrban Arnelo
Urban Arnelo
Background/Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) in children with acute or chronic pancreatitis, or following pancreatic trauma, is technically demanding and may be associated with an increased risk of complications. Evidence on technical success and complication rates in preadolescent children is limited. This study aimed to evaluate the short- and long-term outcomes of ERCP with pancreatic stenting in children with pancreatic conditions. Methods: In this retrospective single-center cohort study, consecutive patients aged ≤12 years who underwent ERCP with pancreatic stenting for acute or chronic pancreatic diseases or pancreatic trauma were included. Demographic, clinical, and procedural data were collected, and complications and clinical response, were assessed. Results: A total of 20 patients (mean age 7 years, range 2–12; 45% female) underwent 62 ERCP procedures for pancreatic indications. Nine patients (45%) had a known genetic mutation. Post-ERCP pancreatitis occurred in 2 procedures (3.2%), and bleeding in 1 procedure (1.6%). No perforations or procedure-related mortality were observed. Technical success was achieved in 57/62 procedures (91.9%), with associated improvement in symptoms, pain, or inflammatory markers. Conclusions: In this pilot study from Sweden, ERCP with pancreatic stenting appears to be a feasible therapeutic option in pre-teen children with pancreatic diseases, with a good technical success rate and relatively low complication rates. Further studies are warranted to better define long-term outcomes in this population.

22 November 2025
Verified
Dataset
Closed access
PDF file
JYJun Yoshino
Jun Yoshino
Alessandro CoppolaAlessandro Coppola
Alessandro Coppola
CSChiara Maria Scandavini
Chiara Maria Scandavini
ISIra Sotirova
Ira Sotirova
IGIoannis Gkekas
Ioannis Gkekas
AHAsif Halimi
Asif Halimi
Pancreatoduodenectomy (PD) is a complex operation, particularly when tumors involve major vessels, including the portal vein and superior mesenteric vein (SMV) or major arteries. To achieve radical surgery, venous resection is often required, and with advancements in neoadjuvant therapy, aggressive surgical approaches, including arterial divestment and resection, are becoming more common. Ideally, a standardized technique should be applied for resectable tumors. In our institution, the right posterior superior mesenteric artery (SMA) approach is routinely performed. This study presents the details of the right posterior SMA approach. The protocol outlines the patient selection criteria, surgical positioning, and step-by-step technical procedures. The right posterior SMA approach begins with exposing the SMV, followed by dissection of the peripancreatic plexus (PLph II) posteriorly from a caudal direction. After anterior dissection of the SMV groove and PLphI, the specimen is removed. This technique enables a clear anatomical boundary, facilitating better visualization and safer resection. Standardizing this approach might enhance oncological outcomes, improve surgical reproducibility, and reduce intraoperative bleeding.

21 November 2025 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
JYJun Yoshino
Jun Yoshino
Alessandro CoppolaAlessandro Coppola
Alessandro Coppola
CSChiara Maria Scandavini
Chiara Maria Scandavini
ISIra Sotirova
Ira Sotirova
IGIoannis Gkekas
Ioannis Gkekas
AHAsif Halimi
Asif Halimi
Pancreatoduodenectomy (PD) is a complex operation, particularly when tumors involve major vessels, including the portal vein and superior mesenteric vein (SMV) or major arteries. To achieve radical surgery, venous resection is often required, and with advancements in neoadjuvant therapy, aggressive surgical approaches, including arterial divestment and resection, are becoming more common. Ideally, a standardized technique should be applied for resectable tumors. In our institution, the right posterior superior mesenteric artery (SMA) approach is routinely performed. This study presents the details of the right posterior SMA approach. The protocol outlines the patient selection criteria, surgical positioning, and step-by-step technical procedures. The right posterior SMA approach begins with exposing the SMV, followed by dissection of the peripancreatic plexus (PLph II) posteriorly from a caudal direction. After anterior dissection of the SMV groove and PLphI, the specimen is removed. This technique enables a clear anatomical boundary, facilitating better visualization and safer resection. Standardizing this approach might enhance oncological outcomes, improve surgical reproducibility, and reduce intraoperative bleeding.